Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Drug and Medication Analysis & Statistics, February 2014 (p4)

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

91-140 of about 5 000 reports
Therapy in Canada: Acute Pain – Pipeline Review, H1 2012

Therapy in Canada: Acute Pain – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Acute Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved ...

  • Industries : Drug and Medication
  • Countries : World
Malignant Pleural Mesothelioma - Pipeline Review, H1 2014

Malignant Pleural Mesothelioma - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Malignant Pleural Mesothelioma - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Malignant Pleural Mesothelioma - Pipeline Review, H1 2014', provides an overview of the Malignant Pleural Mesothelioma's ...

  • Industries : Drug and Medication
  • Countries : World
Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Metastatic Hormone Refractory (Castration Resistant, ...

  • Industries : Drug and Medication
Age Related Macular Degeneration - Pipeline Review, H1 2014

Age Related Macular Degeneration - Pipeline Review, H1 2014

  • $ 2 000
  • Industry report
  • February 2014
  • by Global Markets Direct

Age Related Macular Degeneration - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Age Related Macular Degeneration - Pipeline Review, H1 2014', provides an overview of the Age Related Macula ...

  • Industries : Drug and Medication
  • Countries : United States
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325400

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325400

  • $ 1 995
  • Industry report
  • February 2014
  • by Plunkett Research

Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2020, NAIC 325400 Vital industry-specific data ...

  • Industries : Drug and Medication
  • Countries : United States
Oxaliplatin: Pipeline™ Developer: Patent Report

Oxaliplatin: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Paroxetine: Pipeline™ Developer: Patent Report

Paroxetine: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Octreotide: Pipeline™ Developer: Patent Report

Octreotide: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Leflunomide: Pipeline™ Developer: Patent Report

Leflunomide: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Quetiapine: Pipeline™ Developer: Patent Report

Quetiapine: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Sertraline: Pipeline™ Developer: Patent Report

Sertraline: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Citalopram: Pipeline™ Developer: Patent Report

Citalopram: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Gemcitabine: Pipeline™ Developer: Patent Report

Gemcitabine: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Lansoprazole: Pipeline™ Developer: Patent Report

Lansoprazole: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Pravastatin: Pipeline™ Developer: Patent Report

Pravastatin: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Olanzapine: Pipeline™ Developer: Patent Report

Olanzapine: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Ropivacaine: Pipeline™ Developer: Patent Report

Ropivacaine: Pipeline™ Developer: Patent Report

  • $ 1 954
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Pregabalin: Pipeline™ Developer: Patent Report

Pregabalin: Pipeline™ Developer: Patent Report

  • $ 1 916
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Calcium Signaling Pathway in Cancer Drug Pipeline Update 2014

Calcium Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 159 companies plus partners developing 203 calcium signaling pathway targeting drugs in 799 developmental projects in cancer. In addition, there is 1 suspended drug and the accumulated ...

  • Industries : Drug and Medication
VEGF Signaling Pathway in Cancer Drug Pipeline Update 2014

VEGF Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There is now much evidence that VEGFR-2 is the major mediator of VEGF-driven responses in endothelial cells and it is considered to be a crucial signal transducer in both physiologic and pathologic angiogenesis. ...

  • Industries : Drug and Medication
Gastrointestinal Cancer Drug Pathway Analyzer 2014

Gastrointestinal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 185 targeted molecular therapies known to affect more than 237 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Cell Cycle Targeting in Cancer Drug Pipeline Update 2014

Cell Cycle Targeting in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 144 companies plus partners developing 160 targeting the cell cycle drugs in 536 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ...

  • Industries : Drug and Medication
Breast Cancer Drug Pathway Analyzer 2014

Breast Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 532 targeted molecular therapies known to affect more than 253 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
MicroRNAs in Cancer Drug Pipeline Update 2014

MicroRNAs in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The hot entry of microRNA (miRNA) targeting drugs in oncology may come to revolutionize how we in the near future can launch a highly tumor-specific, multi-targeted attack with minimal toxicities eithe ...

  • Industries : Drug and Medication
Lung Cancer Drug Pipeline Update 2014

Lung Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprises over 95% of all lung cancers. High unmet needs still persist for this tumor type and despite two decades of extensive R&D ...

  • Industries : Drug and Medication
Colorectal Cancer Drug Pathway Analyzer 2014

Colorectal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 375 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2014

Targeting Metabolic Pathways in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

There are today 10 companies plus partners developing 10 metabolic pathways targeting drugs in 22 developmental projects in cancer. In addition, the accumulated number of ceased drugs over the last years ...

  • Industries : Drug and Medication
Lung Cancer Drug Pathway Analyzer 2014

Lung Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 487 targeted molecular therapies known to affect more than 254 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
ErbB Signaling Pathway in Cancer Drug Pipeline Update 2014

ErbB Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

The ErbB family of receptor tyrosine kinases (RTKs) couples binding of extracellular growth factor ligands to intracellular signaling pathways regulating diverse biologic responses, including proliferation, ...

  • Industries : Drug and Medication
Prostate Cancer Drug Pathway Analyzer 2014

Prostate Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • March 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 386 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways ...

  • Industries : Drug and Medication

» View Public Reports

About 12 000 reports

Vaccine Sector Trends

  • Industry report
  • April 2014
  • 40 pages
  • by Intergovernmental Agency

... For ipv introduction ipv vaccine financing and supply unicef awarded a tender for ipv vaccines in february 2014, which makes sufficient quantities of affordable ipv available ipv pricing as of 28 ...


» Read our Company Profiles

83 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.